Found: 61
Select item for more details and to access through your institution.
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
Mast cell cytomorphology and treatment outcome in mast cell leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. E5, doi. 10.1002/ajh.27105
- By:
- Publication type:
- Article
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 1, p. E1, doi. 10.1002/ajh.27089
- By:
- Publication type:
- Article
Bortezomib and daratumumab in refractory autoimmune hemolytic anemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. E263, doi. 10.1002/ajh.27025
- By:
- Publication type:
- Article
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
- By:
- Publication type:
- Article
Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real‐world setting.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 10, p. E377, doi. 10.1002/ajh.26672
- By:
- Publication type:
- Article
A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 491, doi. 10.1002/ajh.26481
- By:
- Publication type:
- Article
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E138, doi. 10.1002/ajh.26464
- By:
- Publication type:
- Article
Venetoclax with azacitidine or decitabine in blast‐phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 781, doi. 10.1002/ajh.26186
- By:
- Publication type:
- Article
Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. E108, doi. 10.1002/ajh.26112
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1511, doi. 10.1002/ajh.25978
- By:
- Publication type:
- Article
Clinical utility of fluorescence in situ hybridization‐based diagnosis of BCR‐ABL1 like (Philadelphia chromosome like) B‐acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. E68, doi. 10.1002/ajh.25729
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. 212, doi. 10.1002/ajh.25688
- By:
- Publication type:
- Article
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 5, doi. 10.1002/ajh.25294
- By:
- Publication type:
- Article
A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 12, p. E401, doi. 10.1002/ajh.25290
- By:
- Publication type:
- Article
Pre‐anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. E144, doi. 10.1002/ajh.25083
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. 578, doi. 10.1002/ajh.24983
- By:
- Publication type:
- Article
Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. E626, doi. 10.1002/ajh.24866
- By:
- Publication type:
- Article
Outcome of elderly patients after failure to hypomethylating agents given as frontline therapy for acute myeloid leukemia: Single institution experience*.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 866, doi. 10.1002/ajh.24780
- By:
- Publication type:
- Article
The prognostic impact of bone marrow fibrosis in primary myelofibrosis.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. E454, doi. 10.1002/ajh.24458
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 3, p. 341, doi. 10.1002/ajh.24284
- By:
- Publication type:
- Article
ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. 653, doi. 10.1002/ajh.24031
- By:
- Publication type:
- Article
Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 651, doi. 10.1002/ajh.23667
- By:
- Publication type:
- Article
CALR mutation studies in chronic neutrophilic leukemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 4, p. 450, doi. 10.1002/ajh.23665
- By:
- Publication type:
- Article
A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
- By:
- Publication type:
- Article
C3+ and C3− warm autoimmune hemolytic anemias: A comparison of clinical characteristics and treatment outcomes.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 1, p. 132, doi. 10.1111/ejh.14212
- By:
- Publication type:
- Article
Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.
- Published in:
- Journal of Clinical Apheresis, 2015, v. 30, n. 3, p. 147, doi. 10.1002/jca.21352
- By:
- Publication type:
- Article
Cutaneous Phototoxicity.
- Published in:
- Toxicologic Pathology, 2016, v. 44, n. 4, p. 545, doi. 10.1177/0192623316643617
- By:
- Publication type:
- Article
Nelarabine in Adult Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma(T-ALL/T-LBL): The Mayo Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S253, doi. 10.1016/j.clml.2017.07.015
- By:
- Publication type:
- Article
Indurated soil nodules: A vestige of ancient agricultural practices?
- Published in:
- Geoarchaeology, 2022, v. 37, n. 6, p. 870, doi. 10.1002/gea.21926
- By:
- Publication type:
- Article
One thousand patients with essential thrombocythemia: the Mayo Clinic experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00972-x
- By:
- Publication type:
- Article
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
- By:
- Publication type:
- Article
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
- By:
- Publication type:
- Article
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Published in:
- 2023
- By:
- Publication type:
- Letter
Mayo Clinic experience with 1123 adults with acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00435-1
- By:
- Publication type:
- Article
A population-based study of chronic neutrophilic leukemia in the United States.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Thalidomide treatment in myelofibrosis with myeloid metaplasia.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 2, p. 288, doi. 10.1046/j.1365-2141.2002.03443.x
- By:
- Publication type:
- Article
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.
- Published in:
- British Journal of Haematology, 2001, v. 114, n. 1, p. 111, doi. 10.1046/j.1365-2141.2001.02883.x
- By:
- Publication type:
- Article
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 3, p. 237, doi. 10.1111/j.1600-0609.2011.01727.x
- By:
- Publication type:
- Article
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 1, p. 43, doi. 10.1111/j.1600-0609.2010.01448.x
- By:
- Publication type:
- Article
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 5, p. 397, doi. 10.1111/j.1600-0609.2008.01037.x
- By:
- Publication type:
- Article
Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
- Published in:
- European Journal of Haematology, 2002, v. 68, n. 3, p. 175, doi. 10.1034/j.1600-0609.2002.01534.x
- By:
- Publication type:
- Article
A LiDAR-based geopedologic approach to address pre-Hispanic agricultural landscapes in Northern Michoacán, West Mexico.
- Published in:
- Boletín de la Sociedad Geológica Mexicana, 2022, v. 74, n. 3, p. 1, doi. 10.18268/BSGM2022v74n3a180622
- By:
- Publication type:
- Article
Apparent Failure of Moxifloxacin to Prevent Ciprofloxacin- and Levofloxacin-Susceptible Pseudomonas aeruginosa Bacteremia in Neutropenic Patients Undergoing Peripheral Blood Stem Cell Transplantation.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 975, doi. 10.1111/bjh.17932
- By:
- Publication type:
- Article
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 413, doi. 10.1111/bjh.17742
- By:
- Publication type:
- Article
Venetoclax plus hypomethylating agent in blast‐phase myeloproliferative neoplasm: preliminary experience with 12 patients.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. e120, doi. 10.1111/bjh.17084
- By:
- Publication type:
- Article
Response to erythropoiesis‐stimulating agents in patients with WHO‐defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T).
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. e104, doi. 10.1111/bjh.16515
- By:
- Publication type:
- Article
Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 835, doi. 10.1111/bjh.15061
- By:
- Publication type:
- Article